No image
Mitomycin 10mg (Mitomycin C)
Product Overview
| Generic Name | Mitomycin 10mg (Mitomycin C) |
| Brand Name(s) | Mutamycin, Jelmyto, Zusduri, Mitosol |
| Category | Antineoplastic / Cancer |
| Form | Intravenous injection (lyophilized powder vial) |
| Strength | 10 mg vial |
| Therapeutic Class | Other cytotoxic antibiotic |
| ATC Code | L01DC03 |
Manufacturing & Regulatory
| Manufacturer | Salvavidas Pharmaceutical Pvt. Ltd.; Surety Healthcare |
| GMP Compliance | WHO-GMP |
| DMF/CEP | Not publicly disclosed |
| COFEPRIS | Under Registration (2025) |
| Free Sale Certificate | Yes |
Logistics & Export
| MOQ | 5 units |
| Shelf Life | 24 Months |
| Storage | Store at 20–25 °C |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 7 - 10 Business Days |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Supplied per batch upon request |
| SDS-Safety Data Sheet (PDF) | Upon Request, not publicly posted |
| CTD Summary (PDF) | CTD available to regulators; summary available to qualified partners |
Special Notes
Indications & Usage: Mitomycin C is indicated for treatment of gastric, pancreatic, cervical, colon, rectal, bladder, breast cancers. It acts as a bioreductive alkylating agent, causing DNA cross-linking and inhibition of DNA synthesis